Bachem is a leading manufacturer of peptides and oligonucleotides. The company has grown over 50% in the last five years and now offers more than 5,500 different biologically active peptide amino acid derivatives, biochemicals. Its investment plans call for the investment of USD 300 million to continue to pursue its growth strategy.

Award
  • Nominated in 2020

  • Winner in 2021